NEWARK, DE — Uvax Bio, LLC has announced the appointment of Kevin O’Neill as Interim Chief Executive Officer (CEO), succeeding company co-founder Ji Li, Ph.D. The leadership transition comes as the company advances its innovative vaccine development programs targeting a range of challenging diseases.
“The Board welcomes Kevin and is confident he will continue to champion our technology and vaccines while maintaining a focus on our various development programs to advance these candidates into clinical development,” said Stone Wang, Uvax’s Board Chair. “We thank Uvax co-founder Dr. Li for his vision as he led the company through the early-stage development of multiple vaccine candidates and introduced our 1c-SApNP® vaccine nanoparticle technology to a wide range of industry stakeholders.”
Mr. O’Neill brings extensive experience in vaccine development and commercialization. Joining Uvax in 2022 as Senior Vice President of Corporate Strategy, he has played a pivotal role in shaping product and portfolio strategies. His career includes leadership roles at Pfizer Vaccines, where he oversaw global commercialization for Prevnar 13®, and as Managing Partner of LSBS, LLC, a vaccine consulting firm. His expertise spans product launches in vaccines, gastrointestinal, and diabetes treatments.
Under Dr. Li’s leadership, Uvax Bio transitioned its most advanced HIV vaccine into Phase 1 clinical trials, with additional programs underway for SARS-CoV-2, MERS, universal influenza, and RSV. The Board has initiated a 12-month search for a permanent CEO.
Commenting on his new role, Mr. O’Neill stated, “I am honored to take on this role at a pivotal time for Uvax Bio. In 2025, we are poised for significant progress, supported by multiple non-dilutive grants to propel four of our candidates into their next stages of development. We are also excited about additional opportunities for funding and advancement later this year.”
With its innovative 1c-SApNP® technology and a robust pipeline of vaccine candidates, Uvax Bio is positioned for a year of growth and scientific breakthroughs as it moves closer to clinical milestones.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.